Intra-Cellular Therapies Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	40,930	19,012	29,935	30,712	45,092	37,494
Market Cap Growth	-39.48%	-36.49%	-2.53%	-31.89%	20.26%	-
Enterprise Value	48,039	27,330	39,459	35,183	49,488	-
Last Close Price	3250.00	2080.00	3275.00	3360.00	9100.00	7566.67
PE Ratio	-	-	-	11.39	-	-
PS Ratio	3.51	1.71	2.86	2.89	3.81	3.82
PB Ratio	6.85	3.99	2.38	1.90	8.83	4.02
P/TBV Ratio	6.92	5.88	2.66	1.90	8.84	4.03
P/FCF Ratio	-	-	398.99	-	-	-
P/OCF Ratio	-	-	95.05	-	-	-
EV/Sales Ratio	4.12	2.45	3.77	3.31	4.18	-
EV/FCF Ratio	-11.20	-	525.92	-	-	-
Debt / Equity Ratio	2.10	2.46	1.08	0.79	2.58	0.78
Debt / FCF Ratio	-	-	181.40	-	-	-
Asset Turnover	0.48	0.44	0.35	0.41	0.60	-
Inventory Turnover	2.78	3.07	2.78	2.97	3.52	-
Quick Ratio	0.49	0.35	0.98	0.89	0.50	0.90
Current Ratio	0.73	0.62	1.19	1.20	0.69	1.32
Return on Equity (ROE)	-73.36%	-103.66%	-37.78%	25.33%	-36.92%	-
Return on Assets (ROA)	-9.71%	-10.06%	-10.09%	-11.98%	-4.88%	-
Return on Capital (ROIC)	-12.04%	-12.06%	-10.82%	-13.19%	-5.58%	-
Earnings Yield	-9.96%	-41.83%	-9.57%	8.78%	-5.91%	-19.59%
FCF Yield	-10.48%	-22.54%	0.25%	-30.34%	-12.74%	-16.83%
Buyback Yield / Dilution	-1.35%	-	9.33%	-31.17%	-53.77%	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.